| Literature DB >> 12415556 |
Ferah Genel1, Serpil Erermis, Guzide Aksu, Can Ozturk, Necil Kutukculer.
Abstract
Psychiatric disorders due to quinacrine for antiparasitic therapy represent an infrequent, but serious, complication. The remarkable course of a 12-year-old boy with common variable immunodeficiency who developed severe psychiatric reactions following quinacrine therapy for his resistant chronic giardiasis is presented. The broad clinical spectrum of quinacrine-associated neuropsychiatric disturbances has been emphasized for the clinicians. Copyright 2002 John Wiley & Sons, Ltd.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12415556 DOI: 10.1002/hup.427
Source DB: PubMed Journal: Hum Psychopharmacol ISSN: 0885-6222 Impact factor: 1.672